Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Acta Paediatrica (Oslo, Norway : 1992)|December 3, 2008
Transcatheter closure of an atrial septal defect in a newborn with aortic stenosisAlbrecht Beitzke, Gerfried Zobel, Bert Nagel, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 22, 2010
Dislocation of a non-functional transvenous ventricular pacemaker lead in a child 6 years following abandonmentBert Nagel, Martin Koestenberger, Igor Knez, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2010
Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous factor Xa and IIa formation and on thrombelastometry profilesGerhard Cvirn, Thomas Wagner, Guenther Juergens, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 23, 2004
Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin timeMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Pediatric Cardiology|April 15, 2009
Femoral vein access by contrast-guided puncture in cardiac catheterization in patients under one year of ageAlbrecht Beitzke, Andreas Gamillscheg, Bert Nagel, et al.
International Journal of Cardiology|November 21, 2018
Tricuspid annular plane systolic excursion (TAPSE) in pediatric pulmonary hypertension: Integrating right ventricular ejection efficiency (RVEe) into advanced multi-parametric imagingMartin Koestenberger, Alexander Avian, Massimiliano Cantinotti, et al.
Thrombosis Research|May 23, 2006
The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CATChristina Cimenti, Martin Koestenberger, Bettina Leschnik, et al.
Pageof 14